Circulating tumour DNA in head and neck squamous-cell carcinomas: A literature review
Cancer Treatment Reviews · 2026-01 · 142 · 103070
DOI: 10.1016/j.ctrv.2025.103070 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-01. Verfasst von Léo Ventelou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Jean PERRIN Center, 63011 Clermont‑Ferrand, France. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck, Biomarkers, Tumor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: In 60 % of cases, head and neck cancers (HNCs) are diagnosed at an advanced stage and therefore have a poor prognosis with survival rates of only 49 months. Circulating tumour DNA (ctDNA) has emerged as a minimally invasive biomarker able to improve early detection, assess minimal residual disease, monitor systemic treatment response and identify therapeutic targets. This literature review aims to critically synthesise evidence from the past decade on the clinical use of ctDNA in both HPV-related and HPV-unrelated HNCs. PATIENTS AND METHODS: A literature review was performed using PubMed and Cochrane Library on March 11th 2024, updated on November 21st, 2025, using the keywords: "circulating tumour DNA", "head and neck cancer", "ctHPV-DNA associated with HNSCC", "liquid biopsy and HNSCC". RESULTS: After evaluation of 363 articles identified, 92 were included. ctDNA has been investigated for screening, diagnosis, prognostic stratification, treatment-response assessment, relapse detection and identification of therapeutic targets. However, performance varies considerably across studies due to methodological and biological heterogeneity. CONCLUSION: ctDNA shows strong potential for response assessment and post-treatment monitoring, particularly in HPV-related disease. Nevertheless, its integration into clinical practice requires methodological standardisation and validation in larger prospective studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Oncology Department, Jean PERRIN Center, 63011 Clermont‑Ferrand, France.
- Clinical Research Division, Delegation for Clinical Research and Innovation, Jean PERRIN Center, 63011 Clermont‑Ferrand, France; INSERM, U1240, Molecular Imaging and Theranostic Strategies, Clermont Auvergne University,…
- OncoGenAuvergne Laboratory, Pathology Unit, Jean PERRIN Center, Clermont‑Ferrand 63011, France.
- Medical Oncology Department, Jean PERRIN Center, 63011 Clermont‑Ferrand, France; Clinical Research Division, Delegation for Clinical Research and Innovation, Jean PERRIN Center, 63011 Clermont‑Ferrand, France; INSERM, U…
- Medical Oncology Department, Jean PERRIN Center, 63011 Clermont‑Ferrand, France; Clinical Research Division, Delegation for Clinical Research and Innovation, Jean PERRIN Center, 63011 Clermont‑Ferrand, France.
Zitieren
APA
Ventelou, L., Ginzac, A., Ferreira, M. C., Canetti, L., Philippe, S., Pinard, C., Durando, X., & Bernadach, M. (2026). Circulating tumour DNA in head and neck squamous-cell carcinomas: A literature review. Cancer Treatment Reviews, 142, 103070. https://doi.org/10.1016/j.ctrv.2025.103070
Vancouver
Ventelou L, Ginzac A, Ferreira MC, Canetti L, Philippe S, Pinard C, et al. Circulating tumour DNA in head and neck squamous-cell carcinomas: A literature review. Cancer Treatment Reviews. 2026;142:103070. doi:10.1016/j.ctrv.2025.103070
BibTeX
@article{Ventelou2026,
author = {Ventelou, Léo and Ginzac, Angeline and Ferreira, Marie-Céleste and Canetti, Laurie and Philippe, Soline and Pinard, Céleste and Durando, Xavier and Bernadach, Maureen},
title = {Circulating tumour DNA in head and neck squamous-cell carcinomas: A literature review},
journal = {Cancer Treatment Reviews},
year = {2026},
volume = {142},
pages = {103070},
doi = {10.1016/j.ctrv.2025.103070}
}
EUVIMED